A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria
Journal of Inherited Metabolic Disease · 2024-07 · 47 (4) · 651-663
DOI: 10.1002/jimd.12719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 23.02.2024. Verfasst von Yvonne Mücke und 7 weiteren Autor:innen. Beteiligte Einrichtung: metaX Institut für Diätetik GmbH, Friedberg, Germany. Hauptthemen laut MEDLINE: Phenylalanine, Phenylketonurias, Recombinant Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BMBF;KMUinnovativ:Biotechnologie-BioChance.
Abstract (Originalsprache)
Phenylketonuria (PKU) is a congenital metabolic disorder that causes the systemic elevation of phenylalanine (Phe), which is neurotoxic and teratogenic. PKU is currently incurable, and management involves lifelong adherence to an unpalatable protein‐restricted diet based on Phe‐free amino acid mixtures. Seeking a palatable dietary alternative, we identified a Bacillus subtilis protein (GSP16O) with a well‐balanced but low‐Phe amino acid profile. We optimized the sequence and expressed a modified Phe‐free version (GSP105) in Pseudomonas fluorescens , achieving yields of 20 g/L. The purified GSP105 protein has a neutral taste and smell, is highly soluble, and remains stable up to 80°C. Homozygous enu2 mice, a model of human PKU, were fed with diets containing either GSP105 or normal protein. The GSP105 diet led to normalization of blood Phe levels and brain monoamine neurotransmitter metabolites, and prevented maternal PKU. The GSP105 diet thus provides an alternative and efficacious dietary management strategy for PKU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- metaX Institut für Diätetik GmbH, Friedberg, Germany.
- Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME, Aachen, Germany.
- Division of Metabolism, Department of Pediatrics, University of Zürich, Zürich, Switzerland.
ORCID-Profile: Yvonne Mücke, Beat Thöny
Förderung
- BMBF;KMUinnovativ:Biotechnologie-BioChance
Zitieren
APA
Mücke, Y., Jablonka, N., Rimann, N., Grisch-Chan, H. M., Hoffmann, B., Schillberg, S., Thöny, B., & Rasche, S. (2024). A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria. Journal of Inherited Metabolic Disease, 47(4), 651-663. https://doi.org/10.1002/jimd.12719
Vancouver
Mücke Y, Jablonka N, Rimann N, Grisch-Chan HM, Hoffmann B, Schillberg S, et al. A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria. Journal of Inherited Metabolic Disease. 2024;47(4):651-663. doi:10.1002/jimd.12719
BibTeX
@article{Mcke2024,
author = {Mücke, Yvonne and Jablonka, Natalia and Rimann, Nicole and Grisch-Chan, Hiu Man and Hoffmann, Bernhard and Schillberg, Stefan and Thöny, Beat and Rasche, Stefan},
title = {A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
volume = {47},
number = {4},
pages = {651--663},
doi = {10.1002/jimd.12719}
}
EUVIMED